Case Report Detection of an MN1::ETV6 Gene Fusion in a Case of Acute Myeloid Leukemia with Erythroid Differentiation: A Case Report and Review of the Literature

,

[1]  A. Tefferi,et al.  Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases , 2022, Blood Cancer Journal.

[2]  Y. Natkunam,et al.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms , 2022, Leukemia.

[3]  A. Rosenwald,et al.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms , 2022, Leukemia.

[4]  V. Najfeld,et al.  Acute myeloid leukemia with an MN1-ETV6 fusion in a young child with Down syndrome , 2022, Cold Spring Harbor molecular case studies.

[5]  Christopher A. Miller,et al.  Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers. , 2021, The New England journal of medicine.

[6]  Fang Wang,et al.  Ectopia associated MN1 fusions and aberrant activation in myeloid neoplasms with t(12;22)(p13;q12) , 2020, Cancer Gene Therapy.

[7]  J. Cen,et al.  Myeloid neoplasms with t(12;22)(p13;q12)/MN1-EVT6: a systematic review of 12 cases , 2018, Annals of Hematology.

[8]  E. De Braekeleer,et al.  ETV6 fusion genes in hematological malignancies: a review. , 2012, Leukemia research.

[9]  T. Haferlach,et al.  ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events , 2012, Genes, chromosomes & cancer.

[10]  Valeria Nofrini,et al.  MN1-ETV6 fusion gene arising from MDS with 5q-. , 2011, Leukemia research.

[11]  S. Jhanwar,et al.  ETV6-ABL1-positive “chronic myeloid leukemia”: clinical and molecular response to tyrosine kinase inhibition , 2011, Haematologica.

[12]  N. Shinton WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .

[13]  Jinlan Pan,et al.  Minimally Differentiated Acute Myeloid Leukemia with t(12;22)(p13;q11) Translocation Showing Primary Multidrug Resistance and Expressing Multiple Multidrug-Resistant Proteins , 2007, Acta Haematologica.

[14]  K. Döhner,et al.  High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. , 2006, Blood.

[15]  S. Bohlander ETV6: a versatile player in leukemogenesis. , 2005, Seminars in cancer biology.

[16]  H. Mizoguchi,et al.  TEL/MN1 fusion in a de novo acute myeloid leukaemia‐M2 patient who showed strong resistance to treatment , 2001, British journal of haematology.

[17]  M. Boavida,et al.  TEL and MN1 Fusion In Myelodysplastic Syndrome: New Evidence For A Therapy‐Related Event , 2000, British journal of haematology.

[18]  Y Fujiwara,et al.  The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. , 1998, Genes & development.

[19]  P. Riegman,et al.  Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. , 1995, Oncogene.